Quarterly Result31 Jan 2026, 04:01 pm
Hindustan Bio Sciences Ltd Announces Q3 2025 Results with 31% YoY Revenue Growth
AI Summary
Hindustan Bio Sciences Ltd has announced its un-audited financial results for the quarter ended 31-12-2025. The company's revenue from operations has grown by 31% YoY. The Board of Directors took these results on record in their meeting on 31st January 2026. The company's total expenses for the quarter stood at INR XX.XX Crores, leading to a profit before tax of INR XX.XX Crores. The company's earnings per equity share for continuing operations were INR XX.XX for the basic and diluted categories.
Key Highlights
- Hindustan Bio Sciences Ltd reported a 31% YoY increase in revenue from operations for Q3 2025.
- The company's total expenses for the quarter stood at INR XX.XX Crores.
- The profit before tax for the quarter was INR XX.XX Crores.
- The earnings per equity share for continuing operations were INR XX.XX for the basic and diluted categories.
- The un-audited financial results were approved by the Board of Directors in their meeting held on 31st January 2026.